Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
3.
Gene ; 530(1): 104-8, 2013 Nov 01.
Article in English | MEDLINE | ID: mdl-23973726

ABSTRACT

BACKGROUND: There is not much information on established standard therapy for patients with severe methionine adenosyltransferase (MAT) I/III deficiency. CASE PRESENTATION: We report a boy with MAT I/III deficiency, in whom plasma methionine and total homocysteine, and urinary homocystine were elevated. Molecular genetic studies showed him to have novel compound heterozygous mutations of the MAT1A gene: c.191T>A (p.M64K) and c.589delC (p.P197LfsX26). A low methionine milk diet was started at 31 days of age, and during continuing dietary methionine restriction plasma methionine levels have been maintained at less than 750 µmol/L. He is now 5 years old, and has had entirely normal physical growth and psychomotor development. CONCLUSIONS: Although some severely MAT I/III deficient patients have developed neurologic abnormalities, we report here the case of a boy who has remained neurologically and otherwise normal for 5 years during methionine restriction, suggesting that perhaps such management, started in early infancy, may help prevent neurological complications.


Subject(s)
Amino Acid Metabolism, Inborn Errors/genetics , Methionine Adenosyltransferase/deficiency , Methionine Adenosyltransferase/genetics , Amino Acid Metabolism, Inborn Errors/pathology , Child, Preschool , Glycine N-Methyltransferase/deficiency , Heterozygote , Homocysteine/blood , Homocysteine/urine , Humans , Male , Methionine/blood , Mutation , Nervous System Diseases/genetics , Nervous System Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...